Patent 7531568 was granted and assigned to Plexxikon Inc. on May, 2009 by the United States Patent and Trademark Office.
Compounds are described that are active on at least one of PPARα, PPARδ, and PPARγ, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARγ.